미래에셋 제약/바이오 김승민

Sharing published data and opinions on the Korean/US/Chinese bio industry.

What our data says

• Created between November 2017 and June 2021.
• The 2nd largest Korean-language business channel in our index.
• Of the channels created in the same period, 87% are smaller than this one.
• A typical post is seen by 18% of subscribers — more than in 80% of business channels of similar size.

More Telegram research from TGScope →